Join
Live feed
·
NEWSReleasevia Quantisnow
Ambrx Biopharma Inc. logo
Johnson & Johnson logo

Ambrx Shareholders Approve Acquisition By Johnson & Johnson

ByQuantisnow·Wall Street's wire, on your screen.
AMAM· Ambrx Biopharma Inc.JNJ· Johnson & Johnson
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMAM (Ambrx Biopharma Inc.), JNJ (Johnson & Johnson) and more on Quantisnow.